extensive stage small cell lung cancer
Showing 1 - 25 of 39
Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)
Not yet recruiting
- Extensive Stage Small Cell Lung Cancer
- hSTC810 400 mg + Paclitaxel
- hSTC810 800 mg + Paclitaxel
- (no location specified)
Aug 24, 2023
Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)
Not yet recruiting
- Small Cell Lung Cancer
- +2 more
- Durvalumab
- +3 more
- (no location specified)
Jun 5, 2023
Extensive Stage Small Cell Lung Cancer Trial in Hangzhou (Tislelizumab, Anlotinib)
Recruiting
- Extensive Stage Small Cell Lung Cancer
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Jun 6, 2023
Extensive Stage Small Cell Lung Cancer Trial (Tarlatamab, Carboplatin, Etoposide)
Recruiting
- Extensive Stage Small Cell Lung Cancer
- Tarlatamab
- +4 more
-
Los Angeles, California
- +37 more
Feb 1, 2023
Extensive Stage Small Cell Lung Cancer Trial in France ([177Lu]Lu-DOTA-TATE, Tislelizumab, [68Ga]Ga-DOTA-TATE)
Recruiting
- Extensive Stage Small Cell Lung Cancer
- [177Lu]Lu-DOTA-TATE
- +4 more
-
Lille, France
- +6 more
Jan 23, 2023
Extensive Stage Small Cell Lung Cancer Trial in Shanghai (HLX10, carboplatin and etoposide, )
Active, not recruiting
- Extensive Stage Small Cell Lung Cancer
- HLX10
- +2 more
-
Shanghai, China
- +5 more
Sep 28, 2022
Extensive Stage Small Cell Lung Cancer Trial (HLX10 + chemo (carboplatin-etoposide), Atezolizumab + chemo
Not yet recruiting
- Extensive Stage Small Cell Lung Cancer
- HLX10 + chemotherapy (carboplatin-etoposide)
- Atezolizumab + chemotherapy (carboplatin-etoposide)
- (no location specified)
Jul 19, 2022
Extensive Stage Small Cell Lung Cancer Trial in Chicago, Indianapolis, Iowa City (Cisplatin, Carboplatin, Etoposide)
Recruiting
- Extensive Stage Small Cell Lung Cancer
- Cisplatin
- +4 more
-
Chicago, Illinois
- +2 more
Jul 1, 2022
Extensive Stage Small Cell Lung Cancer Trial in Shanghai (recombinant anti-PD-L1 mAb injection combined with carboplatin and
Recruiting
- Extensive Stage Small Cell Lung Cancer
- recombinant anti-PD-L1 monoclonal antibody injection combined with carboplatin and etoposide
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
May 9, 2022
Adenocarcinoma of the Lung, Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer Trial in Aurora
Completed
- Adenocarcinoma of the Lung
- +7 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Jan 19, 2022
Extensive Stage Small Cell Lung Cancer
Completed
- Extensive Stage Small Cell Lung Cancer
- First line EC/EP+Atezolizumab
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Jan 22, 2022
Simultaneous Liver Metastases Extensive Stage Small Cell Lung
Completed
- Extensive Stage Small Cell Lung Cancer
- First line EC/EP+Atezolizumab
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Jan 22, 2022
Extensive Stage Small Cell Lung Cancer
Completed
- Extensive Stage Small Cell Lung Cancer
- First line EC/EP+Atezolizumab
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Jan 22, 2022
Extensive Stage Small Cell Lung Cancer Trial in Guangzhou (Camrelizumab; apatinib; carboplatin; etoposide)
Recruiting
- Extensive Stage Small Cell Lung Cancer
- Camrelizumab; apatinib; carboplatin; etoposide
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Guangzhou Medical University
Aug 4, 2021
Extensive Stage Small Cell Lung Cancer Trial in Fuzhou (Fluzoparil, Anlotinib)
Not yet recruiting
- Extensive Stage Small Cell Lung Cancer
-
Fuzhou, Fujain, ChinaLiu Zhenhua. ZhuangWu
Jun 17, 2021
Extensive Stage Small Cell Lung Cancer Trial (SHR-1210)
Not yet recruiting
- Extensive Stage Small Cell Lung Cancer
- (no location specified)
Mar 7, 2021
Extensive Stage Small Cell Lung Cancer Trial in Beijing (nab-paclitaxel, Topotecan)
Unknown status
- Extensive Stage Small Cell Lung Cancer
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Dec 27, 2019
Extensive Stage Small Cell Lung Cancer, Healthy, no Evidence of Disease, Limited Stage Small Cell Lung Cancer Trial in Madison
Completed
- Extensive Stage Small Cell Lung Cancer
- +11 more
- exercise intervention
- +3 more
-
Madison, Wisconsin
- +1 more
Nov 14, 2019
Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer Trial in Toronto (topotecan HCl,
Completed
- Extensive Stage Small Cell Lung Cancer
- Recurrent Small Cell Lung Cancer
- topotecan hydrochloride
- 7-hydroxystaurosporine
-
Toronto, Ontario, CanadaPrincess Margaret Hospital Phase 2 Consortium
Jul 20, 2018
Extensive Stage Small Cell Lung Cancer Trial in Winston-Salem (bioelectric impedance analysis)
Terminated
- Extensive Stage Small Cell Lung Cancer
- bioelectric impedance analysis
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jul 3, 2018
Extensive Stage Small Cell Lung Cancer, Solid Tumor Trial in Sacramento (BKM120, cisplatin, etoposide)
Completed
- Extensive Stage Small Cell Lung Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
- BKM120
- +2 more
-
Sacramento, CaliforniaUniversity of California at Davis Cancer Center
Jan 5, 2018
Extensive Stage Small Cell Lung Cancer, Lung Metastases, Malignant Pleural Effusion Trial in Rochester (saracatinib)
Completed
- Extensive Stage Small Cell Lung Cancer
- +3 more
-
Rochester, MinnesotaNorth Central Cancer Treatment Group
Nov 2, 2017
Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer Trial in United States (ziv-aflibercept, topotecan HCl)
Completed
- Extensive Stage Small Cell Lung Cancer
- Recurrent Small Cell Lung Cancer
- ziv-aflibercept
- topotecan hydrochloride
-
Anniston, Alabama
- +256 more
Jul 21, 2017
Extensive Stage Small Cell Lung Cancer Trial in Shenyang (temozolomide)
Unknown status
- Extensive Stage Small Cell Lung Cancer
-
Shenyang, Liaoning, ChinaThe First Affiliated Hospital of China Medical University
Nov 22, 2016
Extensive Stage Small Cell Lung Cancer Trial in United Kingdom (Ipilimumab)
Completed
- Extensive Stage Small Cell Lung Cancer
- Ipilimumab
-
Bournemouth, United Kingdom
- +6 more
Apr 13, 2016